Type 2 Diabetes affects 1.8 million people in Australia but a new clinical study by Endogenex is looking to change that.
In a recent broadcast by 7News Australia, Dr. Adrian Sartorretto describes the basis of the trial, “It offers the (opportunity) of improving blood sugar control while also reducing the medication burden on patients.”
While in the early stages of the study, Australia is one of three study countries (also being done in Netherlands and U.S.) with patients participating in a clinical study evaluating the ReCET procedure to treat Type 2 Diabetes.
Watch full broadcast. (Please note, this is an international link and may not work on all browsers)